Galen to raise $283 million

Women's health company Galen (LSE:GAL; GALN) announced plans to raise 200 million ($283 million) in an open and international offer of ordinary shares and ADSs. The international offer will be to the public in the U.S and institutional investors elsewhere. Selling shareholders will sell up to 100 million worth of shares. Merrill Lynch is bookrunner to the offer and global manager with ABN AMRO Rothschild and Credit Suisse First Boston. Pricing of the deal is expected July 26, when the number of shares to be sold also will be announced. ...